Titel

Merkliste
1 Ergebnisse

Safety and Effectiveness From the Cabotegravir and Rilpivir..:

Jonsson-Oldenbüttel, Celia ; Ghosn, Jade ; van der Valk, Marc...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 96 (2024) 5 - p. 472-480 , 2024

Link: https://doi.org/10.1097/qai.0000000000003448

RT Journal
T1 <Title>Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings</Title>

UL https://suche.suub.uni-bremen.de/peid=cr-10.1097_qai.0000000000003448&Exemplar=1&LAN=DE
				
A1 Jonsson-Oldenbüttel, Celia
A1 Ghosn, Jade
A1 van der Valk, Marc
A1 Florence, Eric
A1 Vera, Francisco
A1 De Wit, Stéphane
A1 Rami, Agathe
A1 Bonnet, Fabrice
A1 Hocqueloux, Laurent
A1 Hove, Kai
A1 Ait-Khaled, Mounir
A1 DeMoor, Rebecca
A1 Bontempo, Gilda
A1 Latham, Christine L.
A1 Gutner, Cassidy A.
A1 Iyer, Supriya
A1 Gill, Martin
A1 Czarnogorski, Maggie
A1 D'Amico, Ronald
A1 van Wyk, Jean
PB Ovid Technologies (Wolters Kluwer Health)
YR 2024
SN 1525-4135
JF JAIDS Journal of Acquired Immune Deficiency Syndromes
VO 96
IS 5
SP 472
OP 480
LK http://dx.doi.org/https://doi.org/10.1097/qai.0000000000003448
DO https://doi.org/10.1097/qai.0000000000003448
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)